Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
Abstract Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapid evolving interstitial lung disease (ILD), driving its mortality. Specific biomarkers associated with the progression of this lung disease are highly needed. We aimed to identify specific biomarkers of SSc-ILD...
Enregistré dans:
Auteurs principaux: | Julien Guiot, Makon-Sébastien Njock, Béatrice André, Fanny Gester, Monique Henket, Dominique de Seny, Catherine Moermans, Michel G. Malaise, Renaud Louis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/332d152eea1a43e2b6806c3da08770b0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
par: P. Jacquerie, et autres
Publié: (2021) -
Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5
par: Xinh-Xinh Nguyen, et autres
Publié: (2021) -
Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening
par: Gema Vallés, et autres
Publié: (2021) -
Cognitive dysfunction in pediatric multiple sclerosis
par: Suppiej A, et autres
Publié: (2014) -
Association of IGFBP3 Gene (rs2854744) Polymorphism and Colorectal Cancer
par: M Arkani, et autres
Publié: (2012)